Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $57.48K in the twelve months ending March 31, 2026, down -91.26% year-over-year. In the year 2025, Provectus Biopharmaceuticals had annual revenue of $336.11K, down -45.54%.

• Revenue (ttm): 57.48K
• Revenue Growth: -91.26%
• P/S Ratio: 455.96
• Revenue / Employee: 9.58K
• Employees: 6
• Market Cap: 26.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	336.11K	-281.03K	-45.54%
Dec 31, 2024	617.14K	59.43K	10.66%
Dec 31, 2023	557.71K	-431.33K	-43.61%
Dec 31, 2022	989.04K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error